DWA
AXSM icon

Dorsey Wright & Associates’s Axsome Therapeutics AXSM Stock Holding History

Dorsey Wright & Associates’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,057
Closed -$21K – 274
2019
Q3 		$21K Hold
1,057
– – 0.01% 134
2019
Q2 		$27K Buy
1,057
+264
+33% +$5.29K 0.01% 135
2019
Q1 		$11K Buy
+793
New +$7.36K ﹤0.01% 165

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dorsey Wright & Associates's AXSM Position: Q4 2019 in Review

Dorsey Wright & Associates sold out of Axsome Therapeutics (AXSM) in Q4 2019, closing a stake of 1,057 shares — an estimated $21K sold.

Dorsey Wright & Associates first reported a position in AXSM in Q1 2019 and held it in 3 quarters. The position peaked at $27K in Q2 2019. 169 funds tracked by Wall St. Rank hold AXSM as of Q4 2019.

  • Dorsey Wright & Associates reported no remaining Axsome Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,057 Axsome Therapeutics shares in Q4 2019, an estimated $21K.
  • Dorsey Wright & Associates first reported a position in Axsome Therapeutics in Q1 2019 and held it in 3 quarters.
  • Dorsey Wright & Associates's Axsome Therapeutics position peaked at $27K in Q2 2019.
  • 169 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2019.

Based on Dorsey Wright & Associates's 13F filing for Q4 2019, filed 31 Jan 2020.